# China NMPA Drug Inspection - Dongguan Yangzhikang Pharmaceutical Co., Ltd. - Olmesartan medoxomil tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/dongguan-yangzhikang-pharmaceutical-co-ltd/df53c8f8-bdd7-44b3-82e9-8b8a7cc440c4/
Source feed: China

> China NMPA drug inspection for Dongguan Yangzhikang Pharmaceutical Co., Ltd. published June 17, 2021. Drug: Olmesartan medoxomil tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 4, 2021)
- Company Name: Dongguan Yangzhikang Pharmaceutical Co., Ltd.
- Publication Date: 2021-06-17
- Drug Name: Olmesartan medoxomil tablets
- Inspection Finding: Meets the requirements of drug standards (qualified)
- Action Taken: It does not involve the investigation and handling of substandard drugs.

Company: https://www.globalkeysolutions.net/companies/dongguan-yangzhikang-pharmaceutical-co-ltd/9997a730-4765-4d64-bd2d-1e906fdd19b0/